Oncology Biosimilars Market 2021 Competitive Landscape, Future Trends, Size, Share And Growth Analysis

1
Oncology Biosimilars Market, 2021 - 2027
Copyright Precision Business Insights
2
Market Overview
There are several factors that are projected to
drive the oncology biosimilars market over the
forecast duration such as patent expiration of
blockbuster drugs, growing RD activities by the
industry players for the innovation of
biosimilars, and generic drugs, growing demand
for affordable cancer treatments, increasing
cases of certain types of cancers globally and
increase in the funding from public as well as
private sector. The Biosimilars are biological
substances, which are equivalent to biologics
however not the same as patented biological
molecules. Talking about oncology biosimilars,
these work in a same way as oncology biological
molecules work. In addition, the report
discusses the implications of COVID-19, including
the industry's initial response and strategies
for ensuring business continuity in the coming
years. View Detailed Report Description
3
Market Segments
The global oncology biosimilars market has been
fragmented based on 1. By Drugs G-CSF Drugs,
Monoclonal Antibodies, Hematopoietic Drugs,
Others2. By Disease Type Breast Cancer, Lung
Cancer, Colorectal Cancer, Leukemia, Neutropenia,
Blood Cancer, Others3. By Distribution Channel
Hospital Pharmacies, Retail Pharmacies, Online
Pharmacies4. By Geography North America, Asia
Pacific, Europe, Middle East and Africa, Latin
America Request Sample Report
4
Key Players
Some of the major key players in the oncology
biosimilars market areReddys Laboratories
Ltd. (India) Pfizer Inc. (U.S.) Celltrion Inc.
(South Korea) GlaxoSmithKline plc (U.K.) Allergan
Plc. (U.K.) Teva Pharmaceutical Industries Ltd.
(Israel) Sandoz International GmbH (Novartis AG)
(Switzerland) Simcere Pharmaceutical Group
(China) Amgen Inc. (U.S.) Fresenius Kabi AG
(Fresenius SE Co. KGaA) (Germany) Request
Sample Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, 202, RVS Sree Homes, Opp Bharat
Petroleum Pump,Khanamet Road, Hitech City,
Hyderabad, India 500084 Email sales_at_precisionbu
sinessinsights.com Toll Free 1-866-598-1553